Titanium with different oxides: in vitro studies of protein adsorption and contact activation.

Adsorption of albumin (HSA) and fibrinogen (Fib) from human blood plasma onto titanium surfaces with varying oxide properties was studied with an enzyme-linked immunosorbent assay. The intrinsic activation of blood coagulation (contact activation) was studied in vitro using a kallikrein-sensitive substrate. The sample surfaces were characterized with Fourier transform Raman spectroscopy. Auger electron spectroscopy and atomic force microscopy. Low Fib and high HSA adsorption was observed for all titanium samples except for the radio frequency plasma-treated and water-incubated samples, which adsorbed significantly lower amounts of both. Oxide thickness and carbon contamination showed no influence on protein adsorption or contact activation. Smooth samples with a surface roughness (Rrms) < 1 nm showed some correlation between surface wettability and adsorption of Fib and HSA, whereas rough surfaces (Rrms > 5 nm) did not. To varying degrees, all titanium surfaces indicated activation of the intrinsic pathway of coagulation as determined by their kallikrein formation in plasma.

[1]  George A. Parks,et al.  The Isoelectric Points of Solid Oxides, Solid Hydroxides, and Aqueous Hydroxo Complex Systems , 1965 .

[2]  G. Claeson,et al.  Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase. , 1978, Haemostasis.

[3]  G. D. Davis,et al.  Study of titanium oxides using Auger line shapes , 1983 .

[4]  B. Kasemo,et al.  Bone response to surface modified titanium implants: studies on electropolished implants with different oxide thicknesses and morphology. , 1994, Biomaterials.

[5]  R. Colman.  Surface-mediated defense reactions. The plasma contact activation system. , 1984, The Journal of clinical investigation.

[6]  C. Sukenik,et al.  Modulation of cell adhesion by modification of titanium surfaces with covalently attached self-assembled monolayers. , 1990, Journal of biomedical materials research.

[7]  R. A. Silva,et al.  Impedance and photo electrochemical measurements on passive films formed on metallic biomaterials , 1990 .

[8]  B. Kasemo,et al.  Multi-technique surface charaterization of oxide films on electropolished and anodically oxidized titanium , 1990 .

[9]  H. Vinazzer.  Assay of total factor XII and of activated factor XII in plasma with a chromogenic substrate. , 1979, Thrombosis research.

[10]  K. Mittal.  Surface Contamination: An Overview , 1979 .

[11]  T Albrektsson,et al.  Ultrastructural differences of the interface zone between bone and Ti 6Al 4V or commercially pure titanium. , 1989, Journal of biomedical engineering.

[12]  W. Plieth,et al.  Electrochemical synthesis and In situ Raman spectroscopy of thin films of Titanium dioxide , 1991 .

[13]  M. Gallimore,et al.  Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma. , 1982, Thrombosis research.

[14]  I Lundström,et al.  Physico-chemical considerations of titanium as a biomaterial. , 1992, Clinical materials.

[15]  Ingemar Lundström,et al.  Auger electron spectroscopic studies of the interface between human tissue and implants of titanium and stainless steel , 1986 .

[16]  D. H. Kaelble,et al.  Physical chemistry of adhesion , 1971 .

[17]  R. L. Williams,et al.  Electrochemical studies on the influence of proteins on the corrosion of implant alloys. , 1988, Biomaterials.

[18]  B. Kasemo,et al.  Surface science aspects on inorganic biomaterials , 1986 .

[19]  B. Kasemo,et al.  Preparation and surface spectroscopic characterization of oxide films on Ti6Al4V , 1989 .

[20]  P. Tengvall,et al.  An in-vitro study of H2O2-treated titanium surfaces in contact with blood plasma and a simulated body fluid , 1993 .